QA: ADC Therapeutics SA in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001771910_2026_ADC_Therapeutics_SA.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001771910, ADC Therapeutics SA

  xvar xval
0 AssetsCurrent 306,335,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 16,815,000
4 LiabilitiesCurrent 70,163,000
5 LiabilitiesNoncurrent 3,844,000
6 remainder_Liabilities 434,977,000
7 CostOfGoodsAndServicesSold 5,798,000
8 SellingGeneralAndAdministrativeExpense 36,559,000
9 ResearchAndDevelopmentExpense 104,005,000
10 remainder_Expenses 57,509,000
11 remainder_Revenues 81,357,000
12 remainder_NetIncome -20,109,000
13 remainder_ComprehensiveNetIncome 904,000
  yvar yval
0 Assets 323,150,000
1 Liabilities 508,984,000
2 Expenses 203,871,000
3 Revenues 81,357,000
4 StockholdersEquity -185,834,000
5 NetIncome -142,623,000
6 ComprehensiveNetIncome -142,171,000
7 BaseVar 569,187,500
8 EconomicCapitalRatiobeforeLimitedLiability -1.32
9 EconomicCapitalRatio 1.23

Edgar->Model Mapping

Feature Distribution

Change over Time